New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
18:54 EDTGMCR, SD, ELON, BWC, BRKR, ANAD, THOR, NSPH, VMW, LGP, CST, RIG, DEPO, DXCM, JACK, FOX, FOXA, MCPOn The Fly: After Hours Movers
UP AFTER EARNINGS: Molycorp (MCP), up 12.8%... Twenty-First Century Fox (FOXA), up 4.3%... Twenty-First Century Fox (FOX), up 2.3%... Jack in the Box (JACK), up 7.3% after reporting third quarter results above estimates and raising fiscal 2014 EPS view... DexCom (DXCM) up 3.8%... Depomed (DEPO), up 3.1%... Transocean (RIG), up 2.5%. ALSO HIGHER: CST Brands (CST), up 14.8% after announcing that it will acquire the general partner of Lehigh Gas (LGP) for $85M in cash and stock as well as announcing a $200M share repurchase program... Lehigh Gas Partners, up 11.6% after reporting second quarter results and following the announcement that its general partner will be acquired by CST Brands... VMware (VMW), up 1.7% after announcing a $1B share repurchase program. DOWN AFTER EARNINGS: Nanosphere (NSPH), down 34.5%... Thoratec (THOR), down 25.7% after reporting lower than expected second quarter revenues and lowering fiscal 2014 guidance... ANADIGICS (ANAD), down 8.8%... Bruker (BRKR), down 12.7%... Babcock & Wilcox (BWC), down 12.6%... Echelon (ELON), down 14.9% after reporting second quarter results, third quarter guidance below estimates, and announcing that it will scale back its Grid business... SandRidge (SD), down 5%... Keurig Green Mountain (GMCR), down 1.81 following third quarter results.
News For MCP;FOXA;FOX;JACK;DXCM;DEPO;RIG;CST;LGP;VMW;NSPH;THOR;ANAD;BRKR;BWC;ELON;SD;GMCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 22, 2014
06:44 EDTFOXA, FOX'The Maze Runner' leads weekend box office sales with $32.5M, WSJ reports
Subscribe for More Information
06:06 EDTNSPHNanosphere receives deficiency letter from Nasdaq
Subscribe for More Information
September 21, 2014
12:48 EDTRIGTransocean to host special shareholder meeting
Subscribe for More Information
September 19, 2014
17:22 EDTGMCRJudge denies JBR motion blocking sales of Keurig 2.0 brewer, Bloomberg reports
Subscribe for More Information
16:13 EDTGMCRJudge denies JBR motion blocking sales of Keurig 2.0 brewer, Bloomberg reports
11:59 EDTMCPPegasus Partners lowers stake in Molycorp to 3.3%
Pegasus Partners disclosed that from August 19 to August 21, it sold 3.39M shares of Molycorp at average weighted sales prices for each day ranging from $1.85 to $2.07. Pegasus now owns 3.3% of the company's outstanding shares.
11:55 EDTMCPPegasus Partners reports 3.3% stake in Molycorp
Subscribe for More Information
09:19 EDTMCPOn The Fly: Pre-market Movers
Subscribe for More Information
06:08 EDTGMCRKeurig Green Mountain implied volatility of 29 at lower end of index mean range
Subscribe for More Information
September 18, 2014
18:25 EDTMCPOn The Fly: After Hours Movers
HIGHER: Concur (CNQR), up 19.5% after SAP (SAP) announced that it will acquire the company for $129 per share... Navidea Biopharmaceuticals (NAVB), up 9.8% after confirming FDA orphan designation for Lymphoseek... Molycorp (MCP), up 6.1% after Oaktree Capital reported a 9.1% passive stake in the company... JetBlue (JBLU), up 4.6% following CEO transition announcement... Wendy's (WEN), up 2.15% after Trian reported a 24.39% stake in the company... Sears Holdings (SHLD), up 2.6% after Fairholme Capital reported a 24% stake in the company... AMD (AMD), up 1% after announcing that it expanded an IP partnership with Synopsys (SNPS). DOWN AFTER EARNINGS: Red Hat (RHT), down 3%... Oracle (ORCL), down 2.4% following first quarter earnings miss and CEO transition... Tibco Software (TIBX), down 5.5%. ALSO LOWER: Quest Resource (QRHC), down 13.4% after filing an automatic common stock and warrant shelf... Eagle Rock (EROC), down 4.5% after filing to sell 53.34M common units for limited partners... Chatham Lodging (CLDT), down 3.3% after filing to sell 5M shares of common stock... Glu Mobile (GLUU), down 2.3% after filing to sell 9.98M shares of common stock for holders... Blackstone Mortgage (BXMT), down 1.6% after filing to sell 8M shares of common stock.
16:08 EDTMCPOaktree Capital reports 9.1% passive stake in Molycorp
13:05 EDTANADANADIGICS announces WiFi design win with LG Electronics for the G3 Beat
ANADIGICS announced earlier that the company is shipping production volumes of its AWL9280 and AWL9580S WiFi front-end ICs to LG Electronics in support of the global launch of the LG G3 Beat, also known as the LG G3 s in Europe. Shares of ANADIGICS are up more than 4% in afternoon trading.
12:58 EDTVMWEarnings Preview: Morgan Stanley views Oracle's Q1, Q2 estimates as 'achievable'
Subscribe for More Information
07:23 EDTANADCraig-Hallum to hold a conference
Subscribe for More Information
September 17, 2014
16:18 EDTDEPODepomed says FDA recognizing 7 years orphan-drug exclusivity for Gralise in PHN
Depomed (DEPO) disclosed in a filing that on September 16 the company received a letter from the FDA informing the company that pursuant to the order issued on September 5 by a judge of the U.S. District Court for the District of Columbia, the FDA is recognizing seven years of orphan-drug exclusive approval for the company’s Gralise for the management of postherpetic neuralgia. The letter also confirms the FDA will not approve any abbreviated New Drug Application referencing Gralise during the period of orphan-drug exclusive approval, which began on January 28, 2011. The FDA has 60 days after issuance of the order in Depomed, Inc. v. HHS to file a notice appealing the order to the United States Court of Appeals for the Federal Circuit. The period of orphan drug exclusivity applicable to Gralise for PHN is separate from marketing exclusivity arising from the previously disclosed decision issued on August 19 in the company’s patent litigation lawsuit against Actavis (ACT) related to an ANDA filed by Actavis seeking to market generic versions of Gralise. The decision found that Actavis infringed all seven of the company’s patents asserted in the litigation, upheld the validity of the patents and enjoined FDA approval of the Actavis ANDA until February 26, 2024, the latest expiration date of the infringed patents. On September 15, Actavis filed a notice appealing the decision to the United States Court of Appeals for the Federal Circuit, Depomed stated. Previously disclosed settlement agreements between the Company and two other Gralise ANDA filers permit the sale of generic Gralise beginning on January 1, 2024.
13:58 EDTBRKRBruker management to meet with Leerink
Subscribe for More Information
11:41 EDTTHORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
09:04 EDTFOXAmericas Media ad growth estimates lowered at Nomura
Subscribe for More Information
07:56 EDTLGPLehigh Gas price target raised to $42 from $35 at Oppenheimer
Oppenheimer increased its price target on Leigh Gas (LGP) after meeting with the company's management, as the firm expects the stock to rise further as the market digests the company's growth prospects and trading liquidity improves. Oppenheimer thinks that Lehigh Gas' deal with CST Brands (CST) is likely to increase Lehigh's distribution growth next year. The firm keeps an Outperform rating on Lehigh Gas.
06:13 EDTFOXA, FOXSky Deutschland tells investors to reject BSkyB offer
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use